Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC and improve the quality and value of care provided to Medicare beneficiaries. We do not believe that beneficiaries will experience drug access issues as a result of the changes with respect to Part B drugs and discontinuation of payment for preadministration services associated with IVIG. As explained in more detail subsequently in this section, the regulatory provisions may affect beneficiary liability in some cases. Most changes aggregate in beneficiary liability due to a particular provision would be a function of the coinsurance (20 percent if applicable for the particular provision after the beneficiary has met the deductible). Beneficiary liability would also be impacted by the effect of the aggregate cost (savings) of the provision on the standard calculation of the Medicare Part B premium rate (generally 25 percent of the provision's cost or savings). In 2009, total cost sharing (coinsurance and deductible) per Part B enrollee associated with PFS services is estimated to be $468. In addition, the portion of the 2009 standard monthly Part B premium attributable to PFS services is estimated to be $40.10. To illustrate this point, as shown in Table 47, the 2008 national payment amount in the nonfacility setting for CPT code 99203 (Office/outpatient visit, new), is $91.03 1090
CMS-1403-FC which means that in 2008 a beneficiary is responsible for 20 percent of this amount, or $18. Based on this rule, the 2009 national payment amount in the nonfacility setting for CPT code 99203, as shown in Table 47, is $91.97 which means that, in 2009, the beneficiary coinsurance for this service would be $18.39. Policies discussed in this rule that do affect overall spending, such as the additions to the list of codes that are subject to the MPPR for diagnostic imaging, would similarly impact beneficiaries’ coinsurance. W. Accounting Statement As required by OMB Circular A-4 (available at http://www.whitehouse.gov/omb/circulars/a004/a-4.pdf), in Table 53, we have prepared an accounting statement showing the classification of the expenditures associated with this final rule with comment period. This estimate includes the incurred benefit impact associated with the estimated CY 2009 PFS update based on the 2008 Trustees Report baseline, as well as certain MIPPA provisions. All estimated impacts are classified as transfers. 1091
- Page 1039 and 1040: CMS-1403-FC $20 million from what e
- Page 1041 and 1042: CMS-1403-FC ● Impact of Work RVU
- Page 1043 and 1044: CMS-1403-FC imaging services from t
- Page 1045 and 1046: CMS-1403-FC ● Impact of section 1
- Page 1047 and 1048: CMS-1403-FC management, could have
- Page 1049 and 1050: CMS-1403-FC Table 50 illustrates, f
- Page 1051 and 1052: CMS-1403-FC CPT/ HCPCS Mod Descript
- Page 1053 and 1054: CMS-1403-FC impact associated with
- Page 1055 and 1056: CMS-1403-FC The fourth column shows
- Page 1057 and 1058: CMS-1403-FC the CY 2007 claims. The
- Page 1059 and 1060: CMS-1403-FC 1059 4/This column show
- Page 1061 and 1062: CMS-1403-FC requirements is to allo
- Page 1063 and 1064: CMS-1403-FC This amendment of the e
- Page 1065 and 1066: CMS-1403-FC 4 minutes per call, lab
- Page 1067 and 1068: CMS-1403-FC e-prescribing and who m
- Page 1069 and 1070: CMS-1403-FC anti-markup provisions
- Page 1071 and 1072: CMS-1403-FC approximately $50 per h
- Page 1073 and 1074: CMS-1403-FC e-prescribing measure i
- Page 1075 and 1076: CMS-1403-FC we estimate that each e
- Page 1077 and 1078: CMS-1403-FC P. Prohibition Concerni
- Page 1079 and 1080: CMS-1403-FC that provides a calcula
- Page 1081 and 1082: CMS-1403-FC treatment) that occur a
- Page 1083 and 1084: CMS-1403-FC locality (+5.37 percent
- Page 1085 and 1086: CMS-1403-FC additional rental payme
- Page 1087 and 1088: CMS-1403-FC T. Competitive Acquisit
- Page 1089: CMS-1403-FC Program; II.T. Electron
- Page 1093 and 1094: CMS-1403-FC List of Subjects 42 CFR
- Page 1095 and 1096: CMS-1403-FC For the reasons set for
- Page 1097 and 1098: CMS-1403-FC (1) Except as specified
- Page 1099 and 1100: CMS-1403-FC pressure, a visual acui
- Page 1101 and 1102: CMS-1403-FC (ii) A speech-language
- Page 1103 and 1104: CMS-1403-FC during the hours that t
- Page 1105 and 1106: CMS-1403-FC (i) Be certified as a n
- Page 1107 and 1108: CMS-1403-FC 14. Section 410.155 is
- Page 1109 and 1110: CMS-1403-FC prostate cancer screeni
- Page 1111 and 1112: CMS-1403-FC B. Amending the definit
- Page 1113 and 1114: CMS-1403-FC The revisions and addit
- Page 1115 and 1116: CMS-1403-FC or institution other th
- Page 1117 and 1118: CMS-1403-FC substantially all (whic
- Page 1119 and 1120: CMS-1403-FC psychiatric diagnostic
- Page 1121 and 1122: CMS-1403-FC repairing, maintaining,
- Page 1123 and 1124: CMS-1403-FC B. Deleting paragraph (
- Page 1125 and 1126: CMS-1403-FC during any period of me
- Page 1127 and 1128: CMS-1403-FC (c)(1). A. Revising the
- Page 1129 and 1130: CMS-1403-FC * * * * * (b) * * * (2)
- Page 1131 and 1132: CMS-1403-FC assigned to such drug p
- Page 1133 and 1134: CMS-1403-FC 33. In §415.130(d), th
- Page 1135 and 1136: CMS-1403-FC (6) An ambulance provid
- Page 1137 and 1138: CMS-1403-FC §424.57 Special paymen
- Page 1139 and 1140: CMS-1403-FC Final adverse action me
<strong>CMS</strong>-1403-FC<br />
which means that in 2008 a beneficiary is responsible for<br />
20 percent of this amount, or $18. Based on this rule, the<br />
2009 national payment amount in the nonfacility setting for<br />
CPT code 99203, as shown in Table 47, is $91.97 which means<br />
that, in 2009, the beneficiary coinsurance for this service<br />
would be $18.39.<br />
Policies discussed in this rule that do affect overall<br />
spending, such as the additions to the list of codes that<br />
are subject to the MPPR for diagnostic imaging, would<br />
similarly impact beneficiaries’ coinsurance.<br />
W. Accounting Statement<br />
As required by OMB Circular A-4 (available at<br />
http://www.whitehouse.gov/omb/circulars/a004/a-4.pdf), in<br />
Table 53, we have prepared an accounting statement showing<br />
the classification of the expenditures associated with this<br />
final rule with comment period. <strong>This</strong> estimate includes the<br />
incurred benefit impact associated with the estimated<br />
CY 2009 PFS update based on the 2008 Trustees Report<br />
baseline, as well as certain MIPPA provisions. All<br />
estimated impacts are classified as transfers.<br />
1091